Product Code: RP-ID-10012864 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10012864
Market Overview:
Global Hemostats Market Size study, by Product (Thrombin-Based, Oxidized Regenerated Cellulose-Based, Combination, Gelatin-Based, Collagen-Based), by Formulation (Matrix & Gel, Sheet & Pad, Sponge, Powder) by Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Others) and Regional Forecasts 2018-2025
Global Hemostats Market to reach USD 3.5 billion by 2025.
Global Hemostats Market valued approximately USD 2.15 billion in 2017 is anticipated to grow with a healthy growth rate of more than 6.1% over the forecast period 2018-2025.Increasing demand for Hemostats, increasing the number of surgical procedures rising number of regulatory approvals, growing incidence of sports-related injuries and spinal ailments, and increasing effective blood loss of patients during are the major factors which are driving in the growth of the Global Hemostats Market. The increasing number of hospitals and surgical centers are anticipated for further growth in the hemostats market in upcoming period. However, increase in funding in R&D as well as advancement in technology had leaded to increase the market growth. In other word, we can say hemostats as arterial forceps or hemostatic clamp. Generally, the hemostat is a surgical tool which is used during major surgical procedures in order to control blood loss or halt bleeding during surgery. Hemostats consist of a group of instruments that include pivot, tissue holders, needle holders, and various clamps. Due to the presence of a pool of patients throughout the world, Hemostats Market is tremendously growing day by day.
The market of hemostats is segmented by product, formulation, application, and region. On the basis of product, the hemostats market is classified into thrombin-based hemostats oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. With the use of thrombin-based hemostats, hemostats market is expected to its largest growth in its market share. On the basis of formulation, the hemostats market is categorized into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats, and powder hemostats. The sponge hemostat is expected to dominate the demand of market share during forecast period. On the basis of application, the hemostats market is further classified into neurological surgery, cardiovascular surgery, general surgery, orthopedic surgery, thoracic surgery, gynecological surgery, urological surgery, and reconstructive surgery. An increase in the number of surgeries, rise in the incidence of various diseases and increase in concern & awareness about health has turned the market growth to its extent in orthopedic surgeries.
North America contributes to market growth by applying different strategies by market players like new product launches, collaborations in order to enhance the market revenue, joint ventures, agreements and partnerships. It is expected to increase the market demand in Europe and Asia-Pacific region, while North America is leading the consumer of hemostats market.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
 Thrombin-Based Hemostats
 Oxidized Regenerated Cellulose-Based Hemostats
 Combination Hemostats
 Gelatin-Based Hemostats
 Collagen-Based Hemostats
By Formulation:
 Matrix & Gel Hemostats
 Sheet & Pad Hemostats
 Sponge Hemostats
 Powder Hemostats
By Application:
 Orthopedic Surgery
 General Surgery
 Neurological Surgery
 Cardiovascular Surgery
 Reconstructive Surgery
 Gynecological Surgery
 Others Surgery
By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025
The industry is seeming to be fairly competitive. Some of the leading market players include C. R. Bard, B.Braun, Baxter, Integra Lifesciences, Marine Polymer Technologies, Pfizer, Gelita Medical GmbH, Z-Medica, LLC, Ethicon (Subsidiary of Johnson & Johnson), Teleflex Incorporated, CSL Behring, Cryolife, INC., B Braun Melsungen AG and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Global Hemostats Market in Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
B.Braun
Baxter
Integra Lifesciences
Marine Polymer Technologies
Pfizer
Gelita Medical GmbH
Z-Medica, LLC
Ethicon (Subsidiary of Johnson & Johnson)
Teleflex Incorporated
CSL Behring
Cryolife, INC.
B Braun Melsungen AG
Related Reports
Proof of Quality & Reliability
